Placemark Investments’s Immunogen Inc IMGN Stock Holding History

Placemark Investments’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	$225K	Buy	36,883 +803	+2%	+$7.34K	﹤0.01%	1516
2014 Q3	$382K	Buy	36,080 +5,302	+17%	+$60K	0.01%	1293
2014 Q2	$364K	Buy	30,778 +2,824	+10%	+$35.4K	0.01%	1312
2014 Q1	$418K	Buy	27,954 +6,295	+29%	+$99.2K	0.01%	1202
2013 Q4	$315K	Buy	21,659 +2,164	+11%	+$33.3K	0.01%	1328
2013 Q3	$330K	Buy	19,495 +5,756	+42%	+$101K	0.01%	1283
2013 Q2	$228K	Buy	+13,739	New	+$223K	﹤0.01%	1394

Other funds holding IMGN

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Placemark Investments's IMGN Position: Q4 2014 in Review

Placemark Investments increased its Immunogen Inc (IMGN) stake by 2.2% in Q4 2014, buying an estimated $7.34K and bringing the position to 36,883 shares worth $225K. The position accounts for ﹤0.01% of the portfolio, ranked #1516.

Placemark Investments first reported a position in IMGN in Q2 2013 and has held it in 7 quarters since. The position peaked at $418K in Q1 2014. 131 funds tracked by Wall St. Rank hold IMGN as of Q4 2014.

Placemark Investments held 36,883 shares of Immunogen Inc worth $225K as of Q4 2014.
Placemark Investments bought 803 Immunogen Inc shares in Q4 2014, an estimated $7.34K.
Immunogen Inc made up ﹤0.01% of Placemark Investments's portfolio in Q4 2014, its #1516 holding.
Placemark Investments first reported a position in Immunogen Inc in Q2 2013 and has held it in 7 quarters since.
Placemark Investments's Immunogen Inc position peaked at $418K in Q1 2014.
131 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2014.

Based on Placemark Investments's 13F filing for Q4 2014, filed 17 Feb 2015.